| 000 | 01857nam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025551.0 | ||
| 008 | 090402s2009 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng. | |
| 049 | _aDeposite | ||
| 097 | _aPh.D. | ||
| 099 | _aCai01.11.07.Ph.D.2009.Ha.P | ||
| 100 | 0 | _aHadeel Mohammad Mohammad Elhanafi | |
| 245 | 1 | 0 |
_aParaoxonase gene polymorphism as a marker for early microvascular complications in type 1 diabetes mellitus / _cHadeel Mohammad Mohammad Elhanafi ; Supervised Fatma Ahmed Elmougy , Sahar Abdelaty Sharaf , Mona Mamdouh Hassan |
| 246 | 1 | 5 | _aالتعددات الشكلية لجين انزيم الباروكسونيز كدلالة مبكرة لحدوث المضاعفات الخاصة بالأوعية الدموية الدقيقة في مرض البول السكري نوع 1 |
| 260 |
_aCairo : _bHadeel Mohammad Mohammad Elhanafi , _c2009 |
||
| 300 |
_a142P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aHuman serum paraoxonase 1 (PONI) is physiologically associated with HDL and has been implicated in the prevention of LDL lipid peroxidation. The aim of this work is to study the association between PONI activity and gene polymorphism and the presence of microvascular complications in type 1 diabetes mellitus | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHuman serum paraoxonase | |
| 653 | 4 | _aNephropathy | |
| 653 | 4 | _aType 1 diabetes | |
| 700 | 0 |
_aFatma Ahmed Elmougy , _eSupervisor |
|
| 700 | 0 |
_aMona Mamdouh Hassan , _eSupervisor |
|
| 700 | 0 |
_aSahar Abdelaty Sharaf , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c15770 _d15770 |
||